APOE and atherosclerosis: In the present study, we explored the therapeutic potential of mitochondrially-targeted esculetin in mitigating oxidant-induced endothelial cell death and subsequently its effect in regressing Ang-II-induced atherosclerosis in ApoE−/− mice.